If you have started taking a GLP-1 medication like Ozempic, Wegovy or Mounjaro and noticed more hair in your brush, you are not imagining it.
What are GLP-1 medications?
GLP-1 receptor agonists – including semaglutide (sold as Ozempic and Wegovy) and tirzepatide (Mounjaro) – are a class of medication originally developed to manage type 2 diabetes. They’ve since become widely prescribed as weight loss treatments thanks to their ability to suppress appetite and slow digestion.
Their popularity has grown enormously over the last few years, and with that growth has come increased awareness of their side effects – including, for some people, noticeable hair shedding.
Do Ozempic, Wegovy or Mounjaro actually cause hair loss?
This is where things get a little more complicated. Hair loss isn’t a formally listed side effect for Ozempic at standard doses, though some people do report hair thinning or loss while taking it.
The picture is slightly different for higher-dose versions. In clinical trials of Wegovy, around 3% of patients reported hair loss compared to 1% on a placebo, while tirzepatide at its highest dose saw around 5-6% of patients reporting the same.
The NHS’s own guidance on semaglutide now lists hair loss as a common side effect, a notable development given it didn’t feature in earlier prescribing information. What the guidance doesn’t say is that the drug itself is directly to blame.
Rapid weight loss is likely the main cause of GLP-1 hair loss
The current evidence points firmly toward rapid weight loss as the trigger for GLP-1 hair loss, rather than semaglutide acting on hair follicles directly. This is because:
- Rapid weight loss can trigger a condition called telogen effluvium (TE).
- This is a diffuse shedding of hair that happens when a physical stressor causes hair follicles to shift from their active growth phase into a resting phase.
Think of it this way: when your body is under significant physical stress (whether from rapid weight change, nutritional shifts or caloric restriction), it reprioritises its resources. Hair growth, while important to us, is not considered an essential biological function. So follicles temporarily “switch off”, and a few months later, the shedding begins.
TE typically starts 2-3 months after the triggering event and generally settles within 6-9 months as the body stabilises. The shedding can feel dramatic because many follicles enter the resting phase at the same time, but the follicles themselves are not being destroyed.
Who is most at risk?
In the US, FDA guidance suggests GLP-1 hair loss is more common in women (7.1%) than men (0.5%). Nutrient deficiencies caused by restricted calorie intake can compound the problem, with iron, zinc, protein and biotin all playing important roles in hair health.
Fat tissue is also essential for the production of oestrogen, so when fat levels drop, hormonal imbalances can follow. This can further exacerbate hair thinning, particularly in women.
What can you do about GLP-1 hair loss?
The most reassuring thing we can tell you is that hair shedding from GLP-1 medications is typically temporary and caused by metabolic changes from rapid weight loss, not the medication itself. Once your body finds its new balance, shedding typically slows, and healthy regrowth should follow.
In the meantime, there are steps worth taking:
- Support your nutrition with a healthy, well-balanced diet.
- Speak to your GLP-1 prescriber – if shedding is significant, it’s worth having a conversation about the pace of your weight loss.
- Be patient – regrowing hair takes time. Typically, once weight stabilises, the hair should too.
For some patients, particularly where hair loss is more advanced, waiting it out may not do the job. That’s where we come in.
When should you speak to a hair transplant specialist?
If you notice that shedding has revealed a more established pattern of hair loss, or if significant thinning was already present before starting medication, a consultation with our team can help you understand exactly what’s happening and what your options are.
At Crown Clinic, we understand hair loss can be difficult to talk about, which is why our team handles every case with care. Our surgeon, Dr. Shahmalak, is one of the most recognised hair transplant surgeons in the world. Our friendly team will assess your case individually, either at our clinic in Manchester or London, and explain whether a hair transplant is appropriate for you.
To learn more, take a look at our hair transplant case studies or contact us to arrange a consultation.
FAQs
In the vast majority of cases, no. Hair shedding linked to Ozempic and other GLP-1 medications is typically temporary and caused by rapid weight loss rather than the medication directly. Most patients see regrowth once their weight stabilises, though this can take 6-12 months.
There’s no guaranteed way to prevent it entirely, but keeping your protein intake up, maintaining good general nutrition (particularly iron, zinc and biotin), and not losing weight too rapidly can all help reduce the risk.
If shedding is significant, speak to your GP about checking for any underlying deficiencies. For most people, the hair loss is temporary, and regrowth follows once the body adjusts.
Most cases of hair loss linked to GLP-1 medications begin around 2-3 months after weight loss starts – and they typically resolve within 6-12 months once the body stabilises.
You should never stop or adjust your medication without speaking to your prescribing doctor first. Hair shedding, while distressing, is generally temporary. Your GP or prescriber can help you weigh up the benefits of continuing treatment against any side effects you’re experiencing.
